Recital 22, Regulation (EU) 2023/377

In forcesince 15 Feb 2023

For thiabendazole in ‘commodities from bovine’, ‘commodities from goat’, cattle milk, and goat milk, the available data are sufficient to derive an MRL at the LOD of 0,01 mg/kg on the basis of the updated EU livestock dietary burden. Therefore, it is appropriate to set lower MRLs corresponding to MRLs for veterinary medical products set by Commission Regulation (EU) No 37/2010 [Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (OJ L 15, 20.1.2010, p. 1).] [EFSA 2021. Reasoned Opinion on the modification of the existing maximum residue levels and setting of import tolerances for thiabendazole in various crops. EFSA Journal 2021;19(5):6586.], because exposure from use in veterinary medicinal products is expected to be higher than from use in plant protection products. For poultry muscle, poultry fat and ‘bird eggs’, the existing MRLs correspond to CXLs which are not fully supported by data. Therefore, it is appropriate to lower the existing MRLs to the LOD. For all other products of animal origin, the available data are sufficient to derive an MRL at the LOD of 0,01 mg/kg on the basis of the updated EU livestock dietary burden. It is therefore appropriate to lower the existing MRLs to the LOD. The respective footnotes in Annex II highlighting the need for additional data for these products should be deleted. Based on the reasoned opinion of the Authority and taking into account the relevant factors listed in Article 14(2) of Regulation (EC) No 396/2005, it is appropriate to modify the MRLs as set forth in the Annex to this Regulation.